Test cyp powder first appeared in the US drug market in the mid-1950s under the brand name Depo-Testosterone cyclopentylpropionate (soon abbreviated as Depo Testosterone). Now we call it Pharmacia&Upjohn. This is a drug with limited global availability and has been historically (mostly) identified as a US project, as it is relatively rare or absent in other countries. It is not surprising that American athletes have long tended to use Depo Testinstead of other steroids. However, this preference may stem from history and accessibility, rather than based on the actual therapeutic advantages of this product.
What are the structural characteristics of Testosterone Cypionate?
Cypionate Testosterone is a derivative form of testosterone, in which the cyclopentanylpropionate ester has been linked to 17- β On the hydroxyl group. Esterified testosterone has lower polarity than free testosterone and is absorbed more slowly from the area of use. Once entering the bloodstream, the ester is removed to obtain free (active) testosterone. Design esterified forms of testosterone to extend the therapeutic window after administration, allowing for lower frequency of use compared to the use of free (non esterified) steroids. The half-life of Testosterone Cypionate is approximately 8 days.
Applications in the medical field
Testosterone propionate and Testosterone enanthate provide extremely similar testosterone release patterns. The actual differences in pharmacokinetic patterns are almost imperceptible after use (these two drugs are functionally interchangeable for all intents and purposes). The only key difference between the two is the patient's comfort level. For a small number of patients, the stimulation of cyclopentanyl testosterone at the site of use is lower than that of the control substance (Test enan). This difference may be related to the early development of this testosterone ester as a commercial drug product.
The use of TESTOSTERONE CYCLOPENTANE PROPIONATE in clinical medicine has always been a treatment for low androgen levels in men, although this drug is also used for other treatments. For example, in the 1960s, the prescription of drugs pointed out that it could help mature bone structure, treat menorrhagia (menorrhagia), women's excessive breastfeeding, increase muscle mass, and resist osteoporosis in the elderly. It is also recommended for enhancing male fertility, including treating inhibition of testosterone/sperm (caused by weekly administration of 200mg testosterone for 6 to 10 weeks), causing sperm to rebound (temporarily above normal gonadotropin levels).
By the 1970s, the FDA had exercised stronger control over the prescription drug market, and the widespread use of testosterone was refined for the first time. For example, "testosterone rebound therapy" has proven unreliable as a way to increase male fertility, especially when faced with newer and more effective drugs, and was quickly eliminated from prescription guidelines. Recommended for treating excessive menstruation and lactation. Overall, testosterone therapy is being used back to treat male androgen deficiency, with less application in other areas, especially when the population involved is more susceptible to androgenic side effects, such as women and the elderly.
Today, TESTOSTERONE 17BETA-CYCLOPENTANEPROPIONATE can still be used in the US prescription drug market. FDA approved it for male hormone replacement therapy, as well as diseases related to endogenous testosterone deficiency, and as an adjuvant treatment for metastatic breast cancer that women cannot operate on.
This product is currently usable outside of the United States, but not very widely. The international sources of this drug are known to include Canada, Australia, Spain, Brazil, and South Africa, among others.
The information in this article comes from the Internet and is not used as treatment advice or investment advice. If this article has an impact on your rights and interests or is interested in this product, please contact us in time so that we can provide you with more help